Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by Bungeon Nov 17, 2020 10:18am
219 Views
Post# 31913795

RE:RE:Only TLT

RE:RE:Only TLT
Researchbased wrote: You lack understanding Bunge.  That's all.  I was not surprized at all.  I even called to shot to one.

Again, why such a frenzy rush Friday (half day, 5M+ shares), when this was not even yet on in-vivo small animal model and maybe 3 years before commercialization?  Simply because there was "COVID-19" in the header?

Theralase plans to commence an in-vivo small animal study later this year at another facility equipped to handle SARS-CoV-2 viruses and if successful commence human clinical studies in 2021, subject to suitable financing.

It was the total opposite common sense reaction when in 2017, TLT came up with amazing interim data of the first 4 patient (human).  The stock price dropped from 0.40$ to 0.17$, like a rock.  It happened that this was amazing data, for patients that had no more options other than having to go through a high risk 6-7 hours operation to have their bladder completely removed.  One single dose allowed them to avoid the worse.  Market reaction was disproportionate at the time, as P#5 and P#6 data demonstrated thereafter.

But hey!  We're on the TMX-V.  Don't expect common sense.  SONA moved from 0.30$ to 15$ to then 3$ now.  MIR went from 0.03$ to 0.70$ to now 0.25$!  And I can go on and on.

TMX-V stocks get fair valuation only when they approach commercialization.  For the rest, it's just manipulation, no matter the direction of the share price.  So no need to bash on the management, neither be surprized of anything.  You just have to undersatnd the environment in which you invest.  Something, once again, that you have a hard time to assess.  A bit lke your HCQ plots, etc ...



Don't know why I bother...

Again:

As bencro you were the #1 pumper on the board 8 YEARS ago @ 78 cents on only petri dish results.

Now complete reversal.

I'm simply saying irrational exuberance has propelled many small stocks with COVID headlines like that into 2X, 4X, 6X territory.

Not good ol' TLT though.

Are you the one getting all the actual valuable posters here banned now?

Bullboard Posts